计算溶液所需的质量、体积或浓度。
为什么选择此级别
，适用于对基线干扰要求严格的色谱和分析工作流程。
储存与运输
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
质量文档
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
文献证明
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
概述
BRM/BRG1 ATP Inhibitor-1 是变构双 Brahma 同源物 (BRM)/SWI/SNF 相关的基质相关肌动蛋白依赖性调节剂，染色质亚家族 A 成员 2 和 BRG1/SMARCA4 ATP 酶活性抑制剂，IC50值低于 0.005 μM。
BRM/BRG1 ATP Inhibitor-1 (compound 14) is an orally active allosteric dual brahma homolog (BRM) /SWI/SNF related matrix associated actin dependent regulator of chromatin subfamily A member 2 (SMARCA2) and brahma related gene 1 (BRG1)/SMARCA4 ATPase activity inhibitor, both IC 50 s are below 0.005 µM. BRM/BRG1 ATP Inhibitor-1 has anticancer activity
In Vitro
BRM/BRG1 ATP Inhibitor-1 (compound 14) (0-10 μM, 5 days) can inhibit the proliferation of cancer cells. ?\nBRM/BRG1 ATP Inhibitor-1 inhibits KRT80 gene expression in H1299 cells with the AAC 50 (absolute AC 50 ) value of 0.01 μM and in RERF-LC-AI cells with an AAC 50 value of 0.01 μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: SKMEL5 melanoma cells and SBC-5 small cell carcinoma Concentration: 0-10 μM Incubation Time: 5 days Result: Inhibited the proliferation of SKMEL5 cells with an AAC 50 (absolute AC 50 ) value of 0.004 μM and of SBC-5 cells with the AAC 50 more than 10 μM.
In Vivo
BRM/BRG1 ATP Inhibitor-1 (compound 14) (oral administration, 7.5 or 20 mg/kg, everyday, 3 weeks) can inhibit tumor growth and inhibit KRT80 expression in a dose-dependent manner . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female athymic nude mice with RERF-LC-AI tumor xenografts Dosage: 7.5 mg/kg, 20 mg/kg Administration: Oral administration; everyday; 3 weeks Result: Inhibited tumor growth by 21% and 55% at doses of 7.5 mg/kg and 20 mg/kg, respectively. Inhibited KRT80 expression by up to 90% at 20 mg/kg for 7 hours after administration.
IC50& Target:IC50: ﹤0.005 µM (BRM, BRG1)
规格
别名
BRM/BRG1 ATP 抑制剂-1
规格或纯度
10mM in DMSO
英文名称
BRM/BRG1 ATP Inhibitor-1
生化机理
BRM/BRG1 ATP 抑制剂-1（化合物 14）是一种口服活性双梵天同源物 (BRM) /SWI/SNF 相关基质相关肌动蛋白依赖性调节器染色质亚家族 A 成员 2 (SMARCA2) 和梵天相关基因 1 (BRG1)/SMARCA4 ATP 酶激活剂，可用于抑制梵天同源物 (BRM) /SWI/SNF 相关基质相关肌动蛋白依赖性调节器染色质亚家族 A 成员 2 (SMARCA2) 和梵天相关基因 1 (BRG1)/SMARCA4 ATP 酶激活剂的活性。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
名称和识别符
技术文档
高级数据
质检证书（CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
 J2615157 |
分析证书 | B655000 |
溶液计算器
产品仅提供给经过验证的企业、机构和合格的专业人员用于研发。不适用于人类、动物、诊断或治疗。
Copyright © 2023至今 上海阿拉丁生化科技股份有限公司 保留所有权利。
危险品化学品经营许可证（带存储）